NewGenIvf Group Shares to Reverse Split on Monday, July 6th (NASDAQ:NIVF)

NewGenIvf Group Limited (NASDAQ:NIVF) shares are scheduled to reverse split on Monday, July 6th. The 1-3 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the closing bell on Sunday, July 5th.

NewGenIvf Group Stock Performance

NIVF traded down $0.09 during trading on Thursday, reaching $0.46. 876,271 shares of the company’s stock were exchanged, compared to its average volume of 3,003,845. NewGenIvf Group has a fifty-two week low of $0.43 and a fifty-two week high of $295.17. The company has a quick ratio of 2.98, a current ratio of 3.12 and a debt-to-equity ratio of 0.16. The business has a 50 day moving average price of $0.97 and a 200 day moving average price of $3.34.

NewGenIvf Group (NASDAQ:NIVF) last announced its quarterly earnings results on Tuesday, March 31st. The company reported ($287.24) earnings per share (EPS) for the quarter. The business had revenue of $1.42 million for the quarter. As a group, equities research analysts predict that NewGenIvf Group will post 4.74 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of NewGenIvf Group in a research report on Monday, April 27th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Sell”.

Insiders Place Their Bets

In other NewGenIvf Group news, major shareholder Financial Lp Hrt sold 85,317 shares of the company’s stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $0.80, for a total value of $68,253.60. Following the sale, the insider directly owned 54,561 shares in the company, valued at $43,648.80. This represents a 60.99% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 31.80% of the stock is owned by company insiders.

NewGenIvf Group Company Profile

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.